6 months ago
VERA
AnalystsPaul ChoiPaul Choi's Stock Forecasts
AnalystsPaul Choi
Analyst Ranking
Bottom 6%
#5025 out of 5296 analysts
Average Return
-4.42%
Win Rate
43%35 out of 81
Risk vs Reward
Poor
Good
Paul Choi's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Pandion Therapeutics IncPAND | +218.57% | $18.85 | $60.05 | 2020-08-10 - 2021-03-31 | Strong Buy |
Tesaro IncTSRO | +177.42% | $27.02 | $74.96 | 2018-08-06 - 2019-01-18 | Strong Buy |
Gossamer Bio IncGOSS | +146.15% | $0.52 | $1.28 | 2024-06-17 - 2025-06-16 | Strong Buy |
Kyntra Bio IncKYNB | +96.10% | $353.75 | $13.81 | 2022-11-08 - 2023-11-07 | Strong Sell |
Kyntra Bio IncKYNB | +92.04% | $565.00 | $45.00 | 2023-02-21 - 2024-02-20 | Strong Sell |
Paul Choi Analyst Color
Get additional color on Paul Choi's coverage of popular stocks
6 months ago
CYTK
Paul Choi's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Corvus Pharmaceuticals IncCRVS | 1 | Strong Buy | $40.00 | +236.13% | Initiates Coverage On | 2 months ago |
Regenxbio IncRGNX | 4 | Hold | $12.00 | +69.73% | Maintains | 4 months ago |
Vera Therapeutics IncVERA | 1 | Strong Buy | $95.00 | +177.45% | Maintains | 6 months ago |
Cytokinetics IncCYTK | 3 | Strong Buy | $95.00 | +33.09% | Upgrades | 6 months ago |
Ptc Therapeutics IncPTCT | 8 | Strong Sell | $50.00 | -34.87% | Maintains | 7 months ago |
Bridgebio Pharma IncBBIO | 4 | Strong Buy | $100.00 | +47.06% | Maintains | 8 months ago |
Kiniksa Pharmaceuticals International PLCKNSA | 2 | Strong Buy | $55.00 | +5.08% | Maintains | 8 months ago |
Arvinas IncARVN | 4 | Strong Sell | $6.00 | -19.89% | Downgrades | 8 months ago |
Lantheus Holdings IncLNTH | 2 | Hold | $77.00 | -26.44% | Downgrades | 8 months ago |
Edgewise Therapeutics IncEWTX | 1 | Hold | $20.00 | -43.20% | Initiates Coverage On | 9 months ago |
Exelixis IncEXEL | 1 | Strong Buy | $47.00 | -11.32% | Initiates Coverage On | 9 months ago |
Amarin Corp PLCAMRN | 9 | Strong Sell | $12.00 | -21.82% | Maintains | a year ago |
Urogen Pharma LtdURGN | 4 | Hold | $3.00 | N/A | Maintains | a year ago |
Gossamer Bio IncGOSS | 6 | Strong Buy | $8.00 | N/A | Maintains | a year ago |
Phathom Pharmaceuticals IncPHAT | 8 | Hold | $5.00 | N/A | Maintains | a year ago |
Xenon Pharmaceuticals IncXENE | 2 | Strong Buy | $52.00 | N/A | Maintains | a year ago |
Vir Biotechnology IncVIR | 7 | Strong Buy | $21.00 | N/A | Maintains | a year ago |
Esperion Therapeutics IncESPR | 3 | Hold | $3.00 | N/A | Maintains | a year ago |
Dynavax Technologies CorpDVAX | 4 | Strong Sell | $10.00 | N/A | Maintains | a year ago |
Ascendis Pharma AASND | 4 | Strong Buy | $225.00 | N/A | Maintains | a year ago |
Hutchmed LtdHCM | 6 | Hold | $19.00 | N/A | Maintains | 2 years ago |
Foghorn Therapeutics IncFHTX | 2 | Strong Buy | $19.00 | N/A | Maintains | 3 years ago |
Kyntra Bio IncKYNB | 7 | Strong Sell | $50.00 | N/A | Maintains | 3 years ago |
Kinnate Biopharma IncKNTE | 2 | Strong Buy | $26.00 | N/A | Maintains | 3 years ago |
Ngm Biopharmaceuticals IncNGM | 1 | Hold | $4.00 | N/A | Downgrades | 4 years ago |
Ars Pharmaceuticals IncSPRY | 1 | Hold | $3.50 | N/A | Downgrades | 4 years ago |
Allakos IncALLK | 2 | Hold | $60.00 | N/A | Maintains | 4 years ago |
Biohaven Pharmaceutical Holding Co LtdBHVN1 | 1 | Strong Buy | $170.00 | N/A | Maintains | 5 years ago |
Axcella Health IncAXLA | 2 | Hold | $125.00 | N/A | Downgrades | 5 years ago |
Korro Bio IncKRRO | 1 | Hold | $9.00 | N/A | Downgrades | 5 years ago |
Pmv Pharmaceuticals IncPMVP | 2 | Strong Buy | $43.00 | N/A | Upgrades | 5 years ago |
Puma Biotechnology IncPBYI | 4 | Strong Sell | $8.00 | N/A | Maintains | 5 years ago |
Acceleron Pharma IncXLRN | 3 | Hold | $132.00 | N/A | Assumes | 5 years ago |
Radius Health IncRDUS1 | 1 | Strong Buy | $33.00 | N/A | Assumes | 5 years ago |
Springworks Therapeutics IncSWTX | 1 | Strong Buy | $112.00 | N/A | Assumes | 5 years ago |
Myovant Sciences LtdMYOV | 1 | Hold | $30.00 | N/A | Downgrades | 5 years ago |
Pandion Therapeutics IncPAND | 1 | Strong Buy | $28.00 | N/A | Initiates Coverage On | 6 years ago |
Viela Bio IncVIE | 3 | Hold | $49.00 | N/A | Upgrades | 6 years ago |
Global Blood Therapeutics IncGBT | 1 | Strong Buy | $103.00 | N/A | Upgrades | 6 years ago |
Neurocrine Biosciences IncNBIX | 1 | Hold | $135.00 | N/A | Downgrades | 6 years ago |
Dianthus Therapeutics IncDNTH | 1 | Strong Buy | $15.00 | N/A | Upgrades | 6 years ago |
Immunomedics IncIMMU | 2 | Hold | $22.00 | N/A | Upgrades | 6 years ago |
Nektar TherapeuticsNKTR | 2 | Hold | $300.00 | N/A | Upgrades | 6 years ago |
Clovis Oncology IncCLVSQ | 3 | Strong Buy | $40.00 | N/A | Maintains | 8 years ago |
Tesaro IncTSRO | 3 | Strong Buy | $56.00 | N/A | Maintains | 8 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.